Summary3 min read

WSJ Tech News Briefing: TNB Tech Minute – OpenAI Eyes Major Price Cuts Amid Rivalry With Anthropic

Date: June 11, 2026
Host: Danny Lewis

Episode Overview

This Tech Minute briefing delivers a rapid update on the escalating price war between OpenAI and Anthropic in the generative AI space. The episode covers exclusive WSJ reporting on OpenAI considering drastic price reductions, Anthropic’s user backlash over chatbot restrictions, and a new partnership between Nvidia and Abridge to build healthcare-specific AI models.

Key Discussion Points & Insights

1. OpenAI Considers Major Price Cuts to Compete with Anthropic

Exclusive WSJ Report: OpenAI is considering “drastically lowering the prices it charges users as it seeks to win customers from Anthropic.”
- (00:21) “People familiar with the matter say the move by the ChatGPT maker would be in anticipation of similar cuts expected by its rival.”
Rising Enterprise Pressure: “Business executives are beginning to balk at the high prices for AI usage as the two companies are trying to win over enterprise customers.”
Profit Margin Risks: Such drastic cuts could “potentially erode the company’s profit margins, which already lose billions of dollars due to the enormous costs of AI computing resources.”

2. Anthropic Faces User Pushback Over Claude Fable 5 Restrictions

New Claude Model Restrictions: Some users of Anthropic’s latest chatbot model, Claude Fable 5, report “broad restrictions on its capabilities.”
Background: Anthropic originally claimed its previous 'Mythos' model was too dangerous to release widely due to cybersecurity and bioweapon risks.
Community Critique:
- (00:57) “Some AI experts accused Anthropic of hiding some limitations to the update called Claude Fable 5, including quietly degrading the quality of its responses about developing high end AIs, while others found that Fable 5 refused to answer any questions about biology, mathematics and chemistry.”
Company Statement: Anthropic says it “would make some safeguards visible and is working to reduce unnecessary obstructions.”

3. Nvidia Partners with Abridge for Healthcare-Focused AI

Partnership Announcement: Nvidia will train a clinical conversation AI model with Abridge, an AI note-taking company focused on healthcare.
Model Focus: To assist clinical decision support and documentation using de-identified clinical data.
Deployment Timeline: “The new model is expected to be ready for use later this year.”

Notable Quotes & Memorable Moments

OpenAI’s Price Strategy and Industry Impact:

“Drastic price cuts could potentially erode the company’s profit margins, which already lose billions of dollars due to the enormous costs of AI computing resources.” — Danny Lewis (00:35)
Anthropic User Complaints:

“Claude Fable 5 refused to answer any questions about biology, mathematics and chemistry.” — Danny Lewis (01:15)

Timestamps for Key Segments

00:16 – 01:32: Danny Lewis lays out the three major stories (OpenAI price cuts, Anthropic’s AI backlash, Nvidia/Abridge partnership).
01:10 – 01:32: Specific details and expert criticism of Anthropic’s Claude Fable 5 model.
01:33 – 01:52: Nvidia and Abridge partnership news.
[Advertisement and outro sections skipped as instructed]

Original Tone & Language

Danny Lewis delivers news with concise, fact-forward language, directly referencing WSJ’s exclusive reporting and incorporating quotes from AI industry sources. The episode maintains an analytical, business-focused tone befitting The Wall Street Journal’s audience.

Summary at a Glance

OpenAI is prepping for a major price war with Anthropic, aiming to hold or grow its dominance among enterprise users.
Anthropic faces user dissatisfaction after imposing broad restrictions on its latest Claude chatbot, sparking criticism about lack of transparency.
Nvidia is leveraging its AI strengths to co-develop a healthcare model with Abridge, targeting real-world clinical uses.

This Tech Minute keeps listeners at the cutting edge of major moves and controversies shaping the fast-moving AI landscape.

Loading summary

Transcript9 lines

[00:00]
A
Without trusted data, I don't think you have an AI advantage. You may actually be running a high end liability at machine speed.
[00:07]
B
That's Veeam's Shiva Pillay. Join him at the break to learn why trusted data is the fuel that lets AI scale successfully and safely.
[00:17]
C
Here's your T and B Tech minute for Thursday, June 11th. I'm Danny Lewis for the Wall Street Journal. We exclusively report that OpenAI is considering drastically lowering the prices it charges users as it seeks to win customers from Anthropic. People familiar with the matter say the move by the ChatGPT maker would be in anticipation of similar cuts expected by its rival. Business executives are beginning to balk at the high prices for AI usage as the two companies are trying to win over enterprise customers. But drastic price cuts could potentially erode the company's profit margins, which already lose billions of dollars due to the enormous costs of AI computing. Resources News Corp. Owner of the Wall Street Journal, has a content licensing partnership with OpenAI. Speaking of anthropic, the Claude chatbot maker's latest AI model is facing backlash from some users over the broad restrictions on its capabilities. The company previously said its Mythos model was too dangerous to release widely because of fears around cybersecurity and bioweapon development. Some AI experts accused Anthropic of hiding some limitations to the update called Claude Fable 5, including quietly degrading the quality of its responses about developing high end AIs, while others found that Fable 5 refused to answer any questions about biology, mathematics and chemistry. In a statement, Anthropic said it would make some safeguards visible and is working to reduce unnecessary obstructions. Plus in another WSJ exclusive, we report that Nvidia is partnering with Abridge, an AI note taking app maker, to train a model focused on healthcare. The company said the AI is designed for clinical conversations and will be used exclusively within Abridge's platform to improve tasks like clinical decision support and documentation. As part of their work, Abridge will use DE identified clinical data to further train and customize Nvidia's Nemotron suite of open models. The new model is expected to be ready for use later this year. And that's your T and B tech minute. We'll be back this afternoon with more.
[02:11]
B
As companies deploy autonomous AI agents, the guardrails and contextual understanding provided by trusted data are critical. Here again is Shiva Pillai, GM and SVP at Veeam.
[02:21]
A
Agentic AI doesn't wait for governance Agents do not rest the more bad data you're feeding to your models, the more potential harm.
[02:29]
B
Trusted data is also essential to a company's ability to understand, govern, and precisely recover data at the same velocity and scale that AI can act on it.
[02:37]
A
You need surgical precision for AI in data and data sets, particularly in time, as they change you, isolate clean data, validate its integrity, and ensure nothing upstream is compromised. Recovery becomes prioritized by sensitivity to it, not by the size of a workload. So I'm not simply saying go and just recover a whole piece of data. Find me the sensitive data that I need to recover, and why.
[02:59]
B
Visit veeam.com to learn more about how trusted data can power AI at scale.
[03:03]
D
This content was created by custom content from WSJ, a unit of the Wall Street Journal advertising department.